Invesco S&P 500 Equal Weight Health Care ETF (RSPH) Holdings
RSPH holdings summary
as of Oct 24, 2026- Holdings
- 61 positions listed
- Top 10 weight
- 19.4% of net assets
- Effective holdings
- 59 equal-weight equivalent
- Largest holding
- MRNA 2.28% Moderna, Inc.
- Annual turnover
- 26.2% of the portfolio traded
All RSPH holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | MRNA | Moderna, Inc. | Healthcare | 2.28% | $22.0M | $87.04B | — |
| 2 | ISRG | Intuitive Surgical, Inc. | Healthcare | 2.02% | $19.5M | $150.74B | 48.9 |
| 3 | ILMN | Illumina, Inc. | Healthcare | 2.00% | $19.3M | $39.64B | 49.0 |
| 4 | CRL | Charles River Laboratories International, Inc. | Healthcare | 1.95% | $18.8M | $14.46B | — |
| 5 | RVTY | Revvity, Inc. | Healthcare | 1.93% | $18.7M | $17.03B | 73.0 |
| 6 | MTD | Mettler-Toledo International Inc. | Healthcare | 1.93% | $18.6M | $32.51B | 36.6 |
| 7 | VEEV | Veeva Systems Inc. | Healthcare | 1.90% | $18.3M | $50.25B | 50.9 |
| 8 | ABBV | AbbVie Inc. | Healthcare | 1.81% | $17.5M | $504.37B | 80.6 |
| 9 | RMD | ResMed Inc. | Healthcare | 1.79% | $17.3M | $33.61B | 22.9 |
| 10 | A | Agilent Technologies, Inc. | Healthcare | 1.77% | $17.1M | $48.77B | 34.1 |
| 11 | ZTS | Zoetis Inc. | Healthcare | 1.77% | $17.1M | $32.80B | 13.1 |
| 12 | SYK | Stryker Corporation | Healthcare | 1.77% | $17.0M | $113.02B | 30.5 |
| 13 | ELV | Elevance Health Inc. | Healthcare | 1.76% | $17.0M | $92.88B | 19.0 |
| 14 | WST | West Pharmaceutical Services, Inc. | Healthcare | 1.76% | $16.9M | $27.03B | 49.4 |
| 15 | BIIB | Biogen Inc. | Healthcare | 1.75% | $16.8M | $34.37B | 41.3 |
| 16 | BDX | Becton, Dickinson and Company | Healthcare | 1.75% | $16.8M | $52.23B | 44.6 |
| 17 | PODD | Insulet Corporation | Healthcare | 1.74% | $16.7M | $9.79B | 26.4 |
| 18 | DHR | Danaher Corporation | Healthcare | 1.73% | $16.7M | $161.01B | 40.8 |
| 19 | CNC | Centene Corporation | Healthcare | 1.72% | $16.5M | $34.16B | — |
| 20 | IDXX | IDEXX Laboratories, Inc. | Healthcare | 1.71% | $16.5M | $44.20B | 39.8 |
| 21 | GEHC | GE HealthCare Technologies Inc. | Healthcare | 1.70% | $16.4M | $31.42B | 16.0 |
| 22 | WAT | Waters Corporation | Healthcare | 1.69% | $16.3M | $42.90B | 110.6 |
| 23 | CI | Cigna Corporation | Healthcare | 1.69% | $16.3M | $79.88B | 12.5 |
| 24 | VTRS | Viatris Inc. | Healthcare | 1.68% | $16.2M | $21.43B | — |
| 25 | STE | STERIS plc | Healthcare | 1.67% | $16.1M | $21.71B | 27.2 |
| 26 | AMGN | Amgen Inc. | Healthcare | 1.66% | $16.0M | $233.82B | 26.9 |
| 27 | HCA | HCA Healthcare, Inc. | Healthcare | 1.65% | $16.0M | $99.34B | 15.4 |
| 28 | LLY | Eli Lilly and Company | Healthcare | 1.65% | $15.9M | $1.12T | 42.2 |
| 29 | LH | Laboratory Corporation of America Holdings | Healthcare | 1.65% | $15.9M | $25.79B | 26.3 |
| 30 | CAH | Cardinal Health, Inc. | Healthcare | 1.64% | $15.9M | $58.83B | 35.1 |
| 31 | MDT | Medtronic plc | Healthcare | 1.64% | $15.8M | $121.20B | 23.3 |
| 32 | MCK | McKesson Corporation | Healthcare | 1.64% | $15.8M | $117.15B | 26.9 |
| 33 | TMO | Thermo Fisher Scientific Inc. | Healthcare | 1.64% | $15.8M | $255.13B | 37.1 |
| 34 | ZBH | Zimmer Biomet Holdings, Inc. | Healthcare | 1.64% | $15.8M | $18.12B | 23.1 |
| 35 | PFE | Pfizer Inc. | Healthcare | 1.63% | $15.7M | $168.60B | 38.9 |
| 36 | IQV | IQVIA Holdings Inc. | Healthcare | 1.62% | $15.6M | $43.93B | 33.2 |
| 37 | GILD | Gilead Sciences, Inc. | Healthcare | 1.61% | $15.5M | $193.67B | — |
| 38 | UHS | Universal Health Services, Inc. | Healthcare | 1.61% | $15.5M | $10.91B | 7.6 |
| 39 | UNH | UnitedHealth Group Incorporated | Healthcare | 1.60% | $15.5M | $360.32B | 25.8 |
| 40 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | 1.60% | $15.5M | $126.66B | 28.9 |
| 41 | HUM | Humana Inc. | Healthcare | 1.58% | $15.3M | $49.61B | 39.1 |
| 42 | TECH | Bio-Techne Corporation | Healthcare | 1.58% | $15.3M | $11.38B | 62.6 |
| 43 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | 1.57% | $15.2M | $81.41B | 19.6 |
| 44 | CVS | CVS Health Corporation | Healthcare | 1.56% | $15.1M | $118.13B | 24.3 |
| 45 | BAX | Baxter International Inc. | Healthcare | 1.55% | $15.0M | $13.07B | — |
| 46 | JNJ | Johnson & Johnson | Healthcare | 1.55% | $15.0M | $615.87B | 38.8 |
| 47 | COR | Cencora | Healthcare | 1.55% | $15.0M | $65.06B | 25.3 |
| 48 | DGX | Quest Diagnostics Incorporated | Healthcare | 1.55% | $14.9M | $25.94B | 24.6 |
| 49 | BSX | Boston Scientific Corporation | Healthcare | 1.53% | $14.7M | $64.33B | 18.0 |
| 50 | HSIC | Henry Schein, Inc. | Healthcare | 1.51% | $14.6M | $9.63B | 25.2 |
| 51 | EW | Edwards Lifesciences Corporation | Healthcare | 1.51% | $14.6M | $49.92B | 51.5 |
| 52 | MRK | Merck & Co., Inc. | Healthcare | 1.50% | $14.4M | $360.08B | 115.8 |
| 53 | ABT | Abbott Laboratories | Healthcare | 1.49% | $14.4M | $181.50B | 33.8 |
| 54 | DVA | DaVita Inc. | Healthcare | 1.49% | $14.4M | $11.95B | 15.8 |
| 55 | ALGN | Align Technology, Inc. | Healthcare | 1.48% | $14.3M | $10.46B | 25.6 |
| 56 | SOLV | Solventum Corporation | Healthcare | 1.47% | $14.2M | $14.61B | 10.5 |
| 57 | DXCM | DexCom, Inc. | Healthcare | 1.46% | $14.1M | $32.47B | 34.1 |
| 58 | BMY | Bristol-Myers Squibb Company | Healthcare | 1.45% | $14.0M | $122.05B | 13.2 |
| 59 | INCY | Incyte Corporation | Healthcare | 1.43% | $13.8M | $22.92B | 14.4 |
| 60 | COO | The Cooper Companies, Inc. | Healthcare | 1.42% | $13.7M | $11.02B | 19.9 |
| 61 | AGPXX | Invesco Short-Term Investments Trust Government & Agency Portfolio Institutional | Other | 0.01% | $95,518.12 | — | — |
Weights as a percentage of net assets. Value held = weight × net assets ($964.8M). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
RSPH sector breakdown
Sum of the weights of the holdings in each sector.
RSPH top industries
RSPH overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF | 9.5% | 60 of 502 | 0.09% |
| VTI | Vanguard Total Stock Market ETF | 8.4% | 60 of 2,941 | 0.03% |
| DIA | SPDR Dow Jones Industrial Average ETF | 6.3% | 4 of 30 | 0.16% |
| QQQ | Invesco QQQ ETF | 4.4% | 9 of 101 | 0.17% |
| VXUS | Vanguard Total International Stock ETF | 0.0% | 4 of 8,035 | 0.05% |
| IWM | iShares Russell 2000 ETF | 0.0% | 0 of 1,962 | 0.19% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the RSPH portfolio
Invesco S&P 500 Equal Weight Health Care ETF holds 61 positions. The ten largest make up 19.4% of the fund and the top 50 85.3%, so it behaves like a portfolio of about 59 equally weighted stocks. The biggest positions are Moderna, Inc. (2.28%), Intuitive Surgical, Inc. (2.02%), Illumina, Inc. (2.00%), Charles River Laboratories International, Inc. (1.95%), Revvity, Inc. (1.93%).
By sector, Healthcare is 99.97%, Other is 0.0%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 24, 2026; positions change as the fund rebalances.
Related: RSPH chart, RSPH performance, RSPH dividends, RSPH valuation, RSPH overview.
RSPH holdings FAQ
How many holdings does RSPH have?
RSPH holds 61 positions as of October 24, 2026.
What are the top 10 holdings of RSPH?
The ten largest holdings are Moderna, Inc. (2.28%), Intuitive Surgical, Inc. (2.02%), Illumina, Inc. (2.00%), Charles River Laboratories International, Inc. (1.95%), Revvity, Inc. (1.93%), Mettler-Toledo International Inc. (1.93%), Veeva Systems Inc. (1.90%), AbbVie Inc. (1.81%), ResMed Inc. (1.79%), Agilent Technologies, Inc. (1.77%). Together they are 19.4% of the fund.
What percentage of RSPH is Moderna, Inc.?
Moderna, Inc. is the largest holding at 2.28% of net assets, about $22.0M of the fund's $964.8M.
How concentrated is RSPH?
The top 10 holdings are 19.4% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) RSPH behaves like a portfolio of about 59 equally weighted stocks.